{"id":61486,"date":"2025-04-29T23:52:10","date_gmt":"2025-04-29T23:52:10","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/61486\/"},"modified":"2025-04-29T23:52:10","modified_gmt":"2025-04-29T23:52:10","slug":"23andme-will-have-court-appointed-overseer-for-genetic-data-in-bankruptcy","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/61486\/","title":{"rendered":"23andMe will have court-appointed overseer for genetic data in bankruptcy"},"content":{"rendered":"\n<p class=\"yf-1090901\">By Dietrich Knauth<\/p>\n<p class=\"yf-1090901\">NEW YORK (Reuters) -Genetic testing company 23andMe agreed on Tuesday to allow a court-appointed overseer to take charge of ensuring customers&#8217; genetic data remains protected during the company&#8217;s bankruptcy, settling a dispute with several U.S. states.<\/p>\n<p class=\"yf-1090901\">Those states had argued the company was not taking data security seriously enough.<\/p>\n<p class=\"yf-1090901\">U.S. Bankruptcy Judge Brian Walsh approved the agreement at a court hearing in St. Louis, Missouri, ordering the appointment of a consumer protection ombudsman who will be empowered to review 23andMe&#8217;s handling of customers&#8217; genetic information and its security policies.<\/p>\n<p class=\"yf-1090901\">The ombudsman will also review any sale of 23andMe&#8217;s business or data during the company&#8217;s bankruptcy, and report to the court about how any sale would impact customers&#8217; data.<\/p>\n<p class=\"yf-1090901\">23andMe had initially proposed hiring a &#8220;customer data representative&#8221; who would have had a more limited focus on ensuring that a future sale of the company or its data complied with the company&#8217;s existing privacy policies. But a group of more than 25 states objected, saying that 23andMe simply wanted to hire someone who would &#8220;tell this court everything is fine.&#8221;<\/p>\n<p class=\"yf-1090901\">23andMe has collected genetic data from 15 million customers who ordered DNA testing kits online and provided saliva samples to the company. The company has said it won&#8217;t go through with a sale that imperils customers&#8217; genetic data, but the bankruptcy has drawn scrutiny from state attorneys general and lawmakers who warn that customer data could be sold to unscrupulous buyers.<\/p>\n<p class=\"yf-1090901\">The consumer protection ombudsman will have an initial budget of $300,000 for their work, with the ability to ask the court for more money if needed.<\/p>\n<p class=\"yf-1090901\">23andMe filed for bankruptcy last month, seeking to sell its business after a drop-off in consumer demand and a 2023 data breach that exposed millions of customers&#8217; genetic data.<\/p>\n<p class=\"yf-1090901\">The company is still negotiating with potential buyers for its business. It had hoped to name a bidder last week to serve as a minimum bid for other companies to compete against in a future auction. But those talks remain ongoing, and 23andMe has pushed the deadline to April 30, Chris Hopkins, a lawyer for the company, said at Tuesday&#8217;s hearing.<\/p>\n<p class=\"yf-1090901\">23andMe founder Anne Wojcicki has also expressed interest in buying back the company.<\/p>\n<p class=\"yf-1090901\">During the hearing, attorneys representing a class of more than 6 million customers affected by the 2023 data breach raised concerns about the bankruptcy&#8217;s impact on a $30 million settlement reached last year. 23andMe&#8217;s attorneys said the value of the class action settlement is in dispute now that the company is in bankruptcy.<\/p>\n","protected":false},"excerpt":{"rendered":"By Dietrich Knauth NEW YORK (Reuters) -Genetic testing company 23andMe agreed on Tuesday to allow a court-appointed overseer&hellip;\n","protected":false},"author":2,"featured_media":61487,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3846],"tags":[21326,31771,31772,31770,31769,267,70,16,15],"class_list":{"0":"post-61486","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-23andme","9":"tag-brian-walsh","10":"tag-court-hearing","11":"tag-customer-data","12":"tag-genetic-data","13":"tag-genetics","14":"tag-science","15":"tag-uk","16":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114423945421199528","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/61486","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=61486"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/61486\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/61487"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=61486"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=61486"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=61486"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}